DOCS insider filing: 6,360 restricted shares to trade on NYSE Sept 2

Rhea-AI Filing Summary

Doximity, Inc. (DOCS) filing a Form 144 reports a proposed sale of 6,360 restricted common shares with an aggregate market value of $421,655.28, scheduled approximately for 09/02/2025 on the NYSE. The filing shows the shares were acquired as restricted stock on 08/28/2025 and lists total outstanding common shares of 187,299,459. The filer also disclosed sales during the past three months by Timothy Cabral: 20,000 shares sold on 08/15/2025 for $1,275,566.00 and 10,000 shares sold on 06/25/2025 for $600,000.00. Other customary Form 144 statements and signature cautions are included.

Insights

Securities Analyst

TL;DR: Small proposed sale relative to shares outstanding; recent insider sales are disclosed but not evidently material to company fundamentals.

The Form 144 notifies the market of a proposed sale of 6,360 restricted shares valued at $421,655.28, to occur on 09/02/2025 on the NYSE. Relative to the reported 187.3 million shares outstanding, the proposed sale represents a very small fraction of capitalization (approximately 0.0034%). The filing also documents prior insider sales totaling 30,000 shares and $1,875,566 in gross proceeds over the past three months. From a market-impact perspective, these quantities are modest and do not, by themselves, signal a material change to the company’s capital structure or liquidity profile.

Corporate Governance Expert

TL;DR: Filing meets disclosure requirements; documents restricted-stock sale and recent insider dispositions without additional context.

The Form 144 provides required transparency around insider selling and the disposition of restricted stock. It records acquisition of the reported shares as restricted stock on 08/28/2025 and the intended sale date of 09/02/2025. The filing includes the statutory signature representation regarding material nonpublic information. No plan adoption date or 10b5-1 instruction is shown in the supplied content. The document is procedural and consistent with routine insider reporting obligations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6360	421655.28	187299459	09/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/28/2025	Restricted Stock	Issuer			6360	08/28/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
TIMOTHY CABRAL 500 3rd Street Ste 510 San Francisco CA 94107	Common	08/15/2025	20000	1275566.00
TIMOTHY CABRAL 500 3rd Street Ste 510 San Francisco CA 94107	Common	06/25/2025	10000	600000.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Doximity's (DOCS) Form 144 disclose?

The filing discloses a proposed sale of 6,360 restricted common shares valued at $421,655.28, intended for sale on 09/02/2025 on the NYSE.

How many shares has the insider sold recently according to the filing?

The filing reports Timothy Cabral sold 20,000 shares on 08/15/2025 for $1,275,566.00 and 10,000 shares on 06/25/2025 for $600,000.00.

What percentage of outstanding shares does the proposed sale represent?

The proposed sale of 6,360 shares versus 187,299,459 shares outstanding represents approximately 0.0034% of the outstanding common stock.

Were the shares to be sold acquired recently?

Yes. The filing lists the acquisition date for the reported restricted shares as 08/28/2025 with the same date noted for payment as 08/28/2025.

Does the filing state whether a Rule 10b5-1 trading plan was used?

No plan adoption date or explicit Rule 10b5-1 instruction date is provided in the supplied content.